EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer

The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, which binds BRCA2 within a region (exon 3) deleted in cancer. EMSY is capable of silencing the activation potential of BRCA2 exon 3, associates with chromatin regulators HP1beta and BS69, and localizes to sites of repair following DNA damage. EMSY maps to chromosome 11q13.5, a region known to be involved in breast and ovarian cancer. We show that the EMSY gene is amplified almost exclusively in sporadic breast cancer (13%) and higher-grade ovarian cancer (17%). In addition, EMSY amplification is associated with worse survival, particularly in node-negative breast cancer, suggesting that it may be of prognostic value. The remarkable clinical overlap between sporadic EMSY amplification and familial BRCA2 deletion implicates a BRCA2 pathway in sporadic breast and ovarian cancer.

[1]  M. Stratton,et al.  Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. , 1997, British Journal of Cancer.

[2]  Andrew J. Bannister,et al.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain , 2001, Nature.

[3]  J. Simon,et al.  Expression and properties of wild-type and mutant forms of the Drosophila sex comb on midleg (SCM) repressor protein. , 1998, Genetics.

[4]  Stephen P. Jackson,et al.  A role for Saccharomyces cerevisiae histone H2A in DNA repair , 2000, Nature.

[5]  R. Zeillinger,et al.  Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. , 1997, Cancer research.

[6]  Sebastian Maurer-Stroh,et al.  The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. , 2003, Trends in biochemical sciences.

[7]  S. Henikoff,et al.  The HP1 chromo shadow domain binds a consensus peptide pentamer , 2000, Current Biology.

[8]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[9]  Luke Hughes-Davies,et al.  Transcriptional activation functions in BRCA2 , 1997, Nature.

[10]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[11]  Michael L. Blackburn,et al.  An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. , 2003, The Biochemical journal.

[12]  Ashok R Venkitaraman,et al.  Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.

[13]  Karl Mechtler,et al.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins , 2001, Nature.

[14]  B. Rosen,et al.  Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. , 2001, American journal of human genetics.

[15]  Anne E Carpenter,et al.  BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations , 2001, The Journal of cell biology.

[16]  S. Baylin,et al.  Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.

[17]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[18]  S. Jacobs,et al.  Structure of HP1 Chromodomain Bound to a Lysine 9-Methylated Histone H3 Tail , 2002, Science.

[19]  A. Nussenzweig,et al.  Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. , 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[20]  J. D. den Dunnen,et al.  The PWWP domain: a potential protein–protein interaction domain in nuclear proteins influencing differentiation? , 2000, FEBS letters.

[21]  Saul I. Gass,et al.  The Many Faces of OR , 1991 .

[22]  Christophe E. Redon,et al.  Characteristics of γ-H2AX foci at DNA double-strand breaks sites , 2003 .

[23]  F. Christians,et al.  Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1 , 1999, Cell.

[24]  G. Maul,et al.  SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. , 2002, Genes & development.

[25]  A. Wallgren,et al.  A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. , 1998, Cancer research.

[26]  A. Dobrovic,et al.  Methylation of the BRCA1 gene in sporadic breast cancer. , 1997, Cancer research.

[27]  A. Leutz,et al.  The Conserved Mynd Domain of BS69 Binds Cellular and Oncoviral Proteins through a Common PXLXP Motif* , 2002, The Journal of Biological Chemistry.

[28]  B. Ponder,et al.  The Genetics of Inherited Breast Cancer , 1998, Journal of Mammary Gland Biology and Neoplasia.

[29]  R. Shiekhattar,et al.  A core–BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. T. Kadonaga,et al.  The Many Faces of Chromatin Remodeling SWItching beyond Transcription , 2001, Cell.

[31]  D. Birnbaum,et al.  Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. , 1997, Cytogenetics and cell genetics.

[32]  J. Boyd,et al.  Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. , 2000, JAMA.

[33]  Robert L. Sutherland,et al.  Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer , 2003, Breast Cancer Research and Treatment.

[34]  D.,et al.  Regression Models and Life-Tables , 2022 .

[35]  Alexey G. Murzin,et al.  Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9 , 2002, Nature.

[36]  R. Kolodner,et al.  Saccharomyces cerevisiae chromatin-assembly factors that act during DNA replication function in the maintenance of genome stability , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Yamazaki,et al.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage , 2000, Current Biology.

[38]  I. Verma,et al.  BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Prim B. Singh,et al.  Mammalian chromodomain proteins: their role in genome organisation and expression. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[40]  D. Cox.  Regression Models and Life-Tables , 1972 .